238 related articles for article (PubMed ID: 27660276)
1. In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity.
Singh N; Hroudová J; Fišar Z
Mol Neurobiol; 2017 Oct; 54(8):5894-5904. PubMed ID: 27660276
[TBL] [Abstract][Full Text] [Related]
2. Effects of Novel Tacrine Derivatives on Mitochondrial Energy Metabolism and Monoamine Oxidase Activity-In Vitro Study.
Hroudová J; Nováková T; Korábečný J; Maliňák D; Górecki L; Fišar Z
Mol Neurobiol; 2021 Mar; 58(3):1102-1113. PubMed ID: 33089424
[TBL] [Abstract][Full Text] [Related]
3. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
Woodruff-Pak DS; Tobia MJ; Jiao X; Beck KD; Servatius RJ
Neuropsychopharmacology; 2007 Jun; 32(6):1284-94. PubMed ID: 17119537
[TBL] [Abstract][Full Text] [Related]
4. Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism.
Hroudová J; Singh N; Fišar Z; Ghosh KK
Eur J Med Chem; 2016 Oct; 121():774-784. PubMed ID: 27094132
[TBL] [Abstract][Full Text] [Related]
5. Effect of Novel Antipsychotics on Energy Metabolism - In Vitro Study in Pig Brain Mitochondria.
Ľupták M; Fišar Z; Hroudová J
Mol Neurobiol; 2021 Nov; 58(11):5548-5563. PubMed ID: 34365585
[TBL] [Abstract][Full Text] [Related]
6. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.
Gawel K; Labuz K; Gibula-Bruzda E; Jenda M; Marszalek-Grabska M; Filarowska J; Silberring J; Kotlinska JH
Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1059-71. PubMed ID: 27376896
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.
Van Dam D; Abramowski D; Staufenbiel M; De Deyn PP
Psychopharmacology (Berl); 2005 Jun; 180(1):177-90. PubMed ID: 15654502
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
11. Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina.
Bezerra da Silva C; Pott A; Elifio-Esposito S; Dalarmi L; Fialho do Nascimento K; Moura Burci L; de Oliveira M; de Fátima Gaspari Dias J; Warumby Zanin SM; Gomes Miguel O; Dallarmi Miguel M
Molecules; 2016 Jan; 21(1):53. PubMed ID: 26760993
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.
Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
Psychopharmacology (Berl); 2016 Apr; 233(7):1235-43. PubMed ID: 26769042
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice.
Kondak C; Leith M; Baddeley TC; Santos RX; Harrington CR; Wischik CM; Riedel G; Klein J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445987
[TBL] [Abstract][Full Text] [Related]
14. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
Inglis F
Int J Clin Pract Suppl; 2002 Jun; (127):45-63. PubMed ID: 12139367
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
16. Little in vitro effect of remdesivir on mitochondrial respiration and monoamine oxidase activity in isolated mitochondria.
Fišar Z; Ľupták M; Hroudová J
Toxicol Lett; 2021 Oct; 350():143-151. PubMed ID: 34311047
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
18. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Prasher VP
Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
